SNP&SEQ

Job opportunity
 Although we are currently not advertising for any open job positions at the SNP&SEQ Technology Platform you are welcome to send a spontaneous application (CV + personal letter) to:
ann-christine.syvanen@medsci.uu.se.
 We are constantly looking for experienced and skilled research engineers and bioinformaticians.

 The SNP&SEQ Technology Platform offers 'second generation DNA-sequencing' services using two HiSeq 2000 machines from Illumina and one GS-FLX from 454 Life Sciences/Roche. Sequencing applications include sequencing of whole large and small genomes, targeted genomic regions, RNA (cDNA), chromatin-immunoprecipitated DNA and bisulfite-treated DNA on either of these systems.
 

Please choose which system you are interested in:

 

 
  
HiSeq 2000
Illumina		  GS-FLX
454-Roche

                             

 

 

 

 

 

News

  • The Swedish Childhood Cancer Foundation

    2011-12-14

    Molecular Medicine research group has received funding from the Swedish Childhood Cancer Foundation.

  • VR grant

    2011-11-17

    VR-RFI has granted 6.7 million SEK for running costs to the SNP&SEQ platform.

  • K&A Wallenberg grant

    2011-10-04

    Molecular Medicine research group has received funding from the K&A Wallenberg foundation.

  • Publication in Nature

    2011-08-11

    A study that doubles the number of susceptibility genes for multiple sclerosis (MS) was published in Nature on Aug 11.

  • Instrument Upgrade.

    2011-06-20

    The SNP&SEQ Technology Platform have now upgraded our Genome Analyzer IIx with a HiSeq 2000 instrument from Illumina.

  • Publication in Nature Genetics

    2011-03-06

    Five new loci for coronary artery disease were published on-line in Nature Genetics on March 6th.

  • European Project: ESGI

    2011-01-18

    The Molecular Medicine group contributes to the ESGI infra-structure by technology development, eg. allele-specific gene expression and epigenetics.